爱德士 IDXX 深 沪
交易中 10-06 11:18:34 美东时间
519.725
-7.345
-1.39%
华盛通- 最 高562.19
- 今 开529.14
- 成交量 5.50万股
- 最 低 500.61
- 昨 收 527.07
- 总市值 4366.06万
- 52周最高 769.98
- 市盈率 静 60.41
- 换手率 0.07%
- 52周最低 500.61
- 委 比 -77.27%
- 总股本 8.40万
- 历史最高 769.98
- 量 比 0.32
- 振 幅 11.68%
- 历史最低 1.10
- 每 手 1
- 风险率 66.58%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Idexx Laboratories Raises Guidance On Higher Clinical Visits, Diagnostic Frequency
Idexx Laboratories shares edge higher as revenue tops estimates but earnings per share misses; guidance raised.
05-05 22:20
Russell 2000 Rallies, Gold And Silver Extend Losses: What's Moving Markets Monday?
Wall Street rebounded at the start of the new month after Friday's broad sell-off, but pressure on precious metals intensified as investors reassessed the Fed outlook.
02-03 02:40
Why Is IDEXX Labs Stock Falling Today?
IDEXX beat earnings and revenue estimates, boosted by strong pet diagnostics growth, and forecast solid 2026 results as new products and higher testing support momentum.
02-03 02:05
IDEXX Laboratories shares are trading lower. The company reported Q4 financial results.
IDEXX Laboratories shares are trading lower. The company reported Q4 financial ...
02-03 00:51
Earnings Breakdown: IDEXX Laboratories Q4
IDEXX Laboratories (NASDAQ:IDXX) released its Q4 earnings on Monday, February 2...
02-02 19:52
IDEXX Laboratories Q4 Earnings Summary & Key Takeaways
IDEXX Laboratories (NASDAQ:IDXX) just disclosed its Q4 earnings on Monday, Febr...
02-02 19:32
Earnings Scheduled For February 2, 2026
Companies Reporting Before The Bell • Revvity (NYSE:RVTY) is estimated to repor...
02-02 19:11
Peering Into IDEXX Laboratories Inc's Recent Short Interest
IDEXX Laboratories Inc's (NYSE:IDXX) short interest as a percent of float has f...
2025-11-06 22:02
Nvidia, Amazon Extend Rally, Bitcoin Sinks To $107,000: What's Moving Markets Monday?
Wall Street opened the week on a mixed note on Monday.
2025-11-04 02:01
Idexx Laboratories Extends Rally Following Upbeat Q3 Earnings, Outlook
Idexx stock gains after Q3 earnings and revenue beat expectations, driven by strong CAG growth and raised 2025 earnings and sales guidance.
2025-11-03 23:55
